Cargando…
Experimental Priapism is Associated with Increased Oxidative Stress and Activation of Protein Degradation Pathways in Corporal Tissue
Priapism is a debilitating disease for which there is at present no clinically accepted pharmacologic intervention. It has been estimated that priapism lasting more than 24 hours in patients is associated with a 44–90% rate of erectile dysfunction (ED). In this investigation we determined in two ani...
Autores principales: | Kanika, Nirmala D., Melman, Arnold, Davies, Kelvin P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058910/ https://www.ncbi.nlm.nih.gov/pubmed/21085184 http://dx.doi.org/10.1038/ijir.2010.27 |
Ejemplares similares
-
Markers of erectile dysfunction
por: Davies, Kelvin P., et al.
Publicado: (2008) -
Gene Therapy in the Management of Erectile Dysfunction (ED): Past, Present, and Future
por: Melman, Arnold, et al.
Publicado: (2009) -
Opiorphin-dependent up-regulation of CD73 (a key enzyme in the adenosine signaling pathway) in corporal smooth muscle cells exposed to hypoxic conditions and in corporal tissue in pre-priapic sickle cell mice
por: Fu, Shibo, et al.
Publicado: (2015) -
Propofol and priapism
por: Senthilkumaran, Subramanian, et al.
Publicado: (2010) -
Pregabalin and priapism
por: Ramasamy, Ranjith
Publicado: (2014)